The
U.S. Food and Drug Administration (FDA) has required the drug labels and
Medication Guides for all fluoroquinolone antibacterial drugs be updated to
better describe the serious side effect of peripheral neuropathy. This serious
nerve damage potentially caused by fluoroquinolones may occur soon after these
drugs are taken and may be permanent.
The
risk of peripheral neuropathy occurs only with fluoroquinolones that are taken
by mouth or by injection. Approved fluoroquinolone drugs include levofloxacin
(Levaquin), ciprofloxacin (Cipro), moxifloxacin (Avelox), norfloxacin
(Noroxin), ofloxacin (Floxin), and gemifloxacin (Factive). The topical
formulations of fluoroquinolones, applied to the ears or eyes, are not known to
be associated with this risk.
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources